Connect with WiCell at the annual ISSCR 2017 Meeting, June 14-17 

.

There are more than 600 diseases and disorders that affect the nervous system, often resulting in dramatic, long-term impact on patients and their families.  Research to improve our understanding of and advance our ability to treat neurological disease is essential.  Recently there has been an explosion in the number of patient-derived iPS disease model cell lines available to researchers.  These model systems can be used to elucidate underlying mechanisms of disease, investigate genetic impact on disease phenotype, screen drug candidates, investigate therapies, and move toward cures.  This session will focus on recent advances in the field of neurological disease and disorder using pluripotent stem cell modeling as a tool for investigation.  Speakers include those working on specific diseases and disorders (including Zika virus, neuropsychiatric disorders, Alzheimer's disease, ALS, autism, etc.), as well as those working at the stem cell-biomaterial interface to improve disease modeling.    

This session is for investigators with a neural focus, and those interested in PSC disease modeling.

For more information and to view the agenda click here.

Ethics and Regulatory Considerations
Oral Presentation by Dr. Tenneille Ludwig
Room  205-A, Saturday, June 17, 1:15-3:15 pm

Poster presentation by Erik McIntire
Poster # T-2152, Thursday, June 15, 7:00-8:00 pm

   
Poster presentation by Dr. Tenneille Ludwig 
Poster # F-1153, Friday, June 16, 6:00-7:00 pm



  

  Sample Wisconsin cheese, learn more about WiCell  
  WiCell booth 627, Thursday, June 15, 6:00 pm

Attending from WiCell:  Robert Drape, Executive Director
Dr. Tenneille Ludwig, Director of the WiCell Stem Cell Bank 
Jessica Martin Eckery,  Director of Business Operations & Marketing 
Daniel Felkner, Distribution Lab Manager
Seth Taapken, Senior Lab Manager, Cytogenetics
Erik McIntire, Senior Research Specialist, Cytogenetics